FDA Webview
X
latest-news-card-1
Marketing

A new DTC study says drug marketers must learn to market products better to consumers and keep in mi...

latest-news-card-1
Marketing

Bayer uses a "talking" dog and cat in new spots promoting its Advantage prescription flea control to...

latest-news-card-1
Marketing

Pharmacia uses branded DTC television to promote Ambien to adults suffering from sleeplessness.

latest-news-card-1
Marketing

A new report from Families USA ties DTC advertising to projected increases in prescription drug cost...

latest-news-card-1
Marketing

Bristol-Myers Squibb keeps the lid on its DTC plans for just-approved Vaniqa, the first prescription...

latest-news-card-1
Marketing

Although DTC advertising is continuing to grow at double-digit rates, the growth curve has started t...

latest-news-card-1
Marketing

While SmithKline Beecham's Nicorette gum and NicoDerm CQ patch can help address the physical aspects...

latest-news-card-1
Marketing

The battle for COX-2 inhibitor market share between Merck's Vioxx (rofecoxib) and Searle's Celebrex ...

latest-news-card-1
Marketing

CDER's Division of Drug Marketing, Advertising, and Communications says it is concerned about a call...

latest-news-card-1
Marketing

PlanetRx, an Internet health care site, says it has reached a multi-year agreement with Parke-Davis ...

latest-news-card-1
Marketing

Bergen Brunswig says it has reached a preferred systems agreement with PDX, a software provider in t...

latest-news-card-1
Marketing

Nearly one-quarter of all adults online are interested in purchasing prescription drugs over the Int...

latest-news-card-1
Marketing

DDMAC cites another company, Sunnyvale, CA-based Pharmacyclics, for violative promotional activities...

latest-news-card-1
Marketing

Concerned that FDA might not be able to easily obtain the evidence, and that CDER's Division of Drug...

latest-news-card-1
Marketing

Sidley attorneys say the Justice Department voiced strong support for a fraud-on-FDA theory of liabi...

latest-news-card-1
Marketing

FDA accepts for priority review a Capricor Therapeutics BLA for deramiocel, a cell therapy for treat...

latest-news-card-1
Marketing

The CDER Office of Prescription Drug Promotion cautions Taiho Oncology about misleading efficacy pre...

latest-news-card-1
Marketing

The Veeva Field Trends 2022 report says 75% of healthcare providers want contact with drug field sta...

latest-news-card-1
Marketing

CDER advertising researchers say their study of character-space-limited communications like Tweets i...

latest-news-card-1
Marketing

The CDER Office of Prescription Drug Promotion says it wants to expand a current study on endorsers ...